Stability-Indicating HPLC Determination of Gemcitabine in Pharmaceutical Formulations

Development of a gradient high performance liquid chromatography assay for simultaneous analysis of hydrophilic gemcitabine and lipophilic curcumin using a central composite design and its application in liposome development

(2014) Hongtao Xu et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Validated RP-HPLC Method for the Simultaneous Analysis of Gemcitabine and LY-364947 in Liposomal Formulations

(2013) Shyam Bansal et al.   CURRENT DRUG TARGETS

A Stability Indicating RP-HPLC Method for the Estimation of Gemcitabine HCl in Injectable Dosage forms

(2012) Shaik Mastanamma et al.   E-Journal of Chemistry

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

(2012) V. Rajesh et al.   E-Journal of Chemistry

Analysis of gemcitabine liposome injection by HPLC with evaporative light scattering detection

(2012) Qinmei Zhou et al.   JOURNAL OF LIPOSOME RESEARCH

A validated stability-indicating HPTLC method for the estimation of gemcitabine HCl in its dosage form

(2012) Sanjay Borisagar et al.   JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC

Simultaneous quantification of ten cytotoxic drugs by a validated LC–ESI–MS/MS method

(2010) Susanne Nussbaumer et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry

(2007) Elena Marangon et al.   JOURNAL OF MASS SPECTROMETRY